Faslodex (fulvestrant), a new drug for metastatic breast cancer

You'll start hearing about Faslodex (fulvestrant), a new drug for metastatic breast cancer.

It's for postmenopausal women whose cancer progresses on tamoxifen or another antiestrogen.

In these women, Faslodex delays tumor progression at least as well as the aromatase inhibitor Arimidex (anastrozole).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote